Laboratory predictors of clinical outcomes in patients with atrial fibrillation

Laboratory predictors of clinical outcomes in patients with atrial fibrillation

Atrial fibrillation (AF) is the most common cardiac arrhythmia in clinical practice that affects intracardiac hemodynamics and is accompanied by increased mortality due to the risk of stroke and systemic thromboembolism. In recent years, numerous studies, evaluating the use of biomarkers in AF patie...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. A. Sokolova, I. V. Goncharova, A. A. Vedernikov, N. S. Morozova, D. A. Napalkov
Format:	Article
Language:	English
Published:	Столичная издательская компания 2021-05-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	atrial fibrillation nt-probnp troponin т d-dimer biomarkers thromboembolic events
Online Access:	https://www.rpcardio.online/jour/article/view/2444
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Troponin, NT-proBNP and postoperative atrial fibrillation in a prospective cohort undergoing coronary artery bypass surgery
by: Amelie H. Ohlrogge, et al.
Published: (2025-08-01)

N-terminal pro-B-type Natriuretic peptide levels and left atrial appendage thrombosis in patients with persistent atrial fibrillation
by: Chien Do Van, et al.
Published: (2023-11-01)

Predictive Value of N-Terminal Pro B-Type Natriuretic Peptide for Short-Term Outcome of Cardioversion in Patients with First-Diagnosed or Paroxysmal Atrial Fibrillation Presenting to the Emergency Department
by: Antonios Diakantonis, et al.
Published: (2024-12-01)

The role of NT-proBNP in screening for atrial fibrillation in hypertensive disease
by: Gina Sado, et al.
Published: (2024-12-01)

Maximum time between cardiac cycles in atrial fibrillation for assessing the risk of arterial thromboembolism
by: O. A. Germanova, et al.
Published: (2022-08-01)

Optimal choice of prophylactic anticoagulant therapy for nonvalvular atrial fibrillation in the context of COVID-19 pandemic
by: A. S. Polyakov, et al.
Published: (2021-09-01)

Troponin-T as predictor of mortality in patients attending the emergency department with atrial fibrillation
by: Serkan Celik, et al.
Published: (2024-12-01)

Predictive markers of atrial fibrillation in patients after acute ST-elevated myocardial infarction (the results of observational program “FAKEL”)
by: I. A. Zolotovskaya, et al.
Published: (2018-10-01)

Factors determining adherence to anticoagulant therapy in patients with atrial fibrillation
by: D. V. Pevzner, et al.
Published: (2023-06-01)

COMPARISON OF SCHEMES OF PERIOPERATIONAL ANTICOAGULATION IN ATRIAL FIBRILLATION PATIENTS DEMANDING FOR SURGERY
by: L. N. Uddin, et al.
Published: (2018-06-01)

Features of Thromboembolic and Hemorrhagic Complications in Planned Surgical Interventions in Patients with Atrial Fibrillation
by: L. N. Uddin, et al.
Published: (2019-07-01)

Biomarkers of atrial cardiopathy in patients with different pathogenetic subtypes of ischemic stroke
by: S. A. Mekhryakov, et al.
Published: (2020-12-01)

Cost-effectiveness of dabigatran for thromboembolic events prevention in atrial fibrillation patients in Chile
by: Tomás Abbot, et al.
Published: (2025-07-01)

Does perioperative electroacupuncture reduce the incidence of atrial fibrillation after lung cancer surgery? A randomized, controlled, assessor-blinded clinical trial
by: Zheng-qing Zhou, et al.
Published: (2025-05-01)

Cardiac biomarkers for screening and prognostication of cardiac dysfunction in critically ill patients
by: Oscar Cavefors, et al.
Published: (2024-12-01)

Patients with atrial fibrillation and a low risk of thromboembolic events: prescription rate of anticoagulant therapy according to a retrospective analysis
by: M. A. Druzhilov, et al.
Published: (2023-09-01)

Risk of Venous Thromboembolic Complications in Patients with Atrial Fibrillation: a Systematic Review and Meta-analysis
by: A. A. Sokolova, et al.
Published: (2022-07-01)

Cardiorenal relationships in the focus of risks of atrial fibrillation in patients after acute ST-elevated myocardial infarction (observational program FAKEL)
by: I. A. Zolotovskaya, et al.
Published: (2019-05-01)

Cardiac Manifestations and Emerging Biomarkers in Multisystem Inflammatory Syndrome in Children (MIS-C): A Systematic Review and Meta-Analysis
by: Diana-Andreea Ciortea, et al.
Published: (2025-05-01)

MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION
by: E. A. Belikov, et al.
Published: (2015-09-01)

GENETIC PREDICTORS OF ATRIAL FIBRILLATION
by: A. V. Kuskaeva, et al.
Published: (2016-06-01)

IMMEDIATE AND LONG-TERM RESULTS OF THE LEFT ATRIUM AURICLE OCCLUDER IMPLANTING IN ATRIAL FIBRILLATION
by: Z. Kh. Shugushev, et al.
Published: (2016-12-01)

Clinical and prognostic significance of biomarker ratios in patients with heart failure and concomitant atrial fibrillation and diabetes mellitus
by: N.M. Kulaiets, et al.
Published: (2025-04-01)

Prevalence, morphologic characteristic and predictors of organization of atrial auricle thrombi four weeks after anticoagulant preparation to scheduled electrical cardioversion of atrial fibrillation
by: Kalashnykova O.S.
Published: (2013-10-01)

NOVEL ANTICOAGULANTS FOR THROMBOEMBOLIC COMPLICATIONS PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
by: D. A. Itkin, et al.
Published: (2015-02-01)

PREDICTORS OF THE RISK OF HEMORRHAGIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING LONGTERM THERAPY WITH DIRECT ORAL ANTICOAGULANTS
by: A. А. Sokolova, et al.
Published: (2017-12-01)

Predictors of paroxysmal thyrotoxic atrial fibrillation
by: L. N. Berestennikova, et al.
Published: (2011-10-01)

ANTICOAGULANT THERAPY IN EVERYDAY CLINICAL PRACTICE: DATA OF THE RETROSPECTIVE CROSS-SECTIONAL STUDY
by: V. A. Sulimov, et al.
Published: (2015-09-01)

Subclinical Cardiovascular Disease in US Adults With and Without Diabetes
by: Michael Fang, et al.
Published: (2023-06-01)

Cardio-vascular risk in patients with non-valvular persisting atrial fibrillation
by: Kalashnykova O.S.
Published: (2013-06-01)

Elderly Patients with Atrial Fibrillation: Focus on Comorbidity and Safety of Anticoagulant Therapy
by: D. A. Napalkov, et al.
Published: (2019-09-01)

Major bleeding and thromboembolic complications associated with antithrombotic treatment in patients with atrial fibrillation/flutter and incident cancer
by: Gordon Chu, et al.
Published: (2025-02-01)

Atrial fibrillation with thrombotic complications. Justification of the diagnosis and treatment regimen according to evidence-based medicine (clinical case)
by: L.O. Martymianova, et al.
Published: (2024-12-01)

Fibrosis biomarkers as predictors of left atrial appendage thrombosis in patients with nonvalvular atrial fibrillation
by: T. P. Gizatulina, et al.
Published: (2022-08-01)

Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation
by: V. I. Petrov, et al.
Published: (2019-03-01)

Incidence and associated factors with atrial fibrillation in patients with transthyretin amyloidosis cardiomyopathy: Insights from the multicenter REACT-SP registry
by: Cristhian Espinoza Romero, et al.
Published: (2025-06-01)

Atrial Fibrillation: a Marker or Risk Factor for Stroke
by: B. A. Tatarsky, et al.
Published: (2023-03-01)

Major bleeding and thromboembolism risks of antithrombotic treatment in patients with incident atrial fibrillation/flutter and a history of cancer
by: Nienke van Rein, et al.
Published: (2025-02-01)

THE PREDICTION OF ATRIAL FIBRILLATION RECURRENCE AT VARIOUS METHODS OF SINUS RHYTHM RECOVERY
by: T. Y. Gromyko, et al.
Published: (2016-06-01)

Left ventricular diastolic dysfunction and N-terminal probrain sodium-uretic peptid level in patients with atrial fibrillation
by: Dzyak G.V., et al.
Published: (2013-06-01)